From: Prevalence of SARS-CoV-2 infection in neonates born to mothers or relatives with COVID-19
Parameters | Positive | Negative | Total | P. value | |
---|---|---|---|---|---|
No | 25 (25.5%) | 73 (74.5%) | 98 (100%) | – | |
Age of mothers/Years at the time of sampling | 30.2 ± 5.7 (19–39) | 30.9 ± 5.1 (17–41) | 30.8 ± 5.1 (17–41) | 0.533 Student T Test | |
Age groups of mothers (Years) | 15–20 | 1 (4.0%) | 3 (4.1%) | 4 (4.1%) | 0.443 Chi-Square Test |
21–25 | 6 (24.0%) | 6 (8.2%) | 12 (12.2%) | ||
26–30 | 6 (24.0%) | 26 (35.6%) | 32 (32.7%) | ||
31–35 | 6 (24.0%) | 24 (32.8%) | 30 (30.6%) | ||
36–40 | 6 (24.0%) | 12 (16.4%) | 18 (18.4%) | ||
> 40 | 0 (0.0%) | 2 (2.7%) | 2 (2.0%) | ||
Epidemiological characteristics of mothers | |||||
 None | 8 (32.0%) | 60 (82.2%) | 68 (69.4%) | < 0.001aFisher’s exact Test | |
 Fever | 12 (48.0%) | 9 (12.3%) | 21 (21.4%) | < 0.001 aFisher’s exact Test | |
 Chills | 10 (40.0%) | 7 (9.6%) | 17 (17.3%) | < 0.001 aFisher’s exact Test | |
 General weakness | 6 (24.0%) | 3 (4.1%) | 9 (9.2%) | < 0.001 aFisher’s exact Test | |
 Skeletal pain | 3 (12.0%) | 1 (1.4%) | 4 (4.1%) | 0.016 aFisher’s exact Test | |
 Hypertension | 1 (4.0%) | 1 (1.4%) | 2 (2.0%) | 0.410 Fisher’s exact Test | |
 Dyspnea | 1 (4.0%) | 3 (4.1%) | 4 (4.1%) | 0.228 Fisher’s exact Test | |
 Dry cough | 5 (20.0%) | 5 (6.8%) | 10 (10.2%) | 0.007 aFisher’s exact Test | |
 Tachycardia | 0 (0.0%) | 1 (1.4%) | 1 (1.0%) | 0.568 Fisher’s exact Test | |
 Acute respiratory disease | 1 (4.0%) | 1 (1.4%) | 2 (2.0%) | 0.013 aFisher’s exact Test | |
 Decreased sense of smell | 6 (24.0%) | 2 (2.7%) | 8 (8.2%) | < 0.001 aFisher’s exact Test | |
 Decreased sense of taste | 6 (24.0%) | 2 (2.7%) | 8 (8.2%) | < 0.001 aFisher’s exact Test |